North America PCR Technologies Market
The North America PCR Technologies Market size was valued at US$ 5,075.81 Mn in 2022 and is projected to reach US$ 9,634.86 Mn by 2030, growing at a CAGR of 8.3% during 2022 - 2030.
Report Coverage
- Technology: Real-Time PCR, Conventional PCR, Reverse Transcription PCR, Digital PCR, Multiplex RT PCR, Hot Start PCR
- Offerings: Reagents & Consumables, Instruments, Software & Services
- End User: Hospitals & Diagnostic Centers, Academia & Research Institutes, Pharmaceutical & Biotechnology Companies
US$ 5,075.81 Mn
Market size in 2022
US$ 9,634.86 Mn
Market Size by 2030
8.3%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America PCR Technologies Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America PCR Technologies Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America PCR Technologies Market Regional Analysis
6.2 North America PCR Technologies Market Revenue 2020-2030 (US$ Million)
6.3 North America PCR Technologies Market Forecast Analysis
7. North America PCR Technologies Market Analysis – by Technology
7.1 Real-Time PCR
- 7.1.1 Overview
- 7.1.2 Real-Time PCR: North America PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Conventional PCR
- 7.2.1 Overview
- 7.2.2 Conventional PCR: North America PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Reverse Transcription PCR
- 7.3.1 Overview
- 7.3.2 Reverse Transcription PCR: North America PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Digital PCR
- 7.4.1 Overview
- 7.4.2 Digital PCR: North America PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Multiplex RT PCR
- 7.5.1 Overview
- 7.5.2 Multiplex RT PCR: North America PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.6 Hot Start PCR
- 7.6.1 Overview
- 7.6.2 Hot Start PCR: North America PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. North America PCR Technologies Market Analysis – by Offerings
8.1 Reagents & Consumables
- 8.1.1 Overview
- 8.1.2 Reagents & Consumables: North America PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Instruments
- 8.2.1 Overview
- 8.2.2 Instruments: North America PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Software & Services
- 8.3.1 Overview
- 8.3.2 Software & Services: North America PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. North America PCR Technologies Market Analysis – by End User
9.1 Hospitals & Diagnostic Centers
- 9.1.1 Overview
- 9.1.2 Hospitals & Diagnostic Centers: North America PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Academia & Research Institutes
- 9.2.1 Overview
- 9.2.2 Academia & Research Institutes: North America PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Pharmaceutical & Biotechnology Companies
- 9.3.1 Overview
- 9.3.2 Pharmaceutical & Biotechnology Companies: North America PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. North America PCR Technologies Market – North America Analysis
10.1 Overview
10.2 North America- 10.2.1 North America PCR Technologies Market Breakdown, by Key Country, 2023 and 2030 (%)
- 10.2.1.1 North America PCR Technologies Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 US: North America PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 US: North America PCR Technologies Market Breakdown, by Technology
- 10.2.1.1.2 US: North America PCR Technologies Market Breakdown, by Offerings
- 10.2.1.1.3 US: North America PCR Technologies Market Breakdown, by End User
- 10.2.1.2 Canada: North America PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Canada: North America PCR Technologies Market Breakdown, by Technology
- 10.2.1.2.2 Canada: North America PCR Technologies Market Breakdown, by Offerings
- 10.2.1.2.3 Canada: North America PCR Technologies Market Breakdown, by End User
- 10.2.1.3 Mexico : North America PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 Mexico : North America PCR Technologies Market Breakdown, by Technology
- 10.2.1.3.2 Mexico : North America PCR Technologies Market Breakdown, by Offerings
- 10.2.1.3.3 Mexico : North America PCR Technologies Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Promega Corp
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 QIAGEN NV
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 bioMerieux SA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Hoffmann-La Roche Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Bio-Rad Laboratories Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Becton Dickinson and Co
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Atila Biosystems Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Takara Bio Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Standard BioTools Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Agilent Technologies Inc
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Visby Medical Inc
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 Ellume Ltd
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
